Alle Aussendungen Politik Wirtschaft Finanzen Chronik Kultur Medien Karriere Tourismus Bundesländer

Grünenthal Group

Suche in Pressroom

http://www.grunenthal.com/

Aussendungen

Kontaktpersonen

Grünenthal Group

Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia

Aachen, Germany (OTE) - Aachen, Germany (ots)

02.06.2025, 10:00:33
/
OTE0002

Grünenthal Group

Maren Thurow starts as new Head Global Communications at Grünenthal

Aachen (OTE) - Maren Thurow has today assumed the role of Vice President and Head Global Communications at Grünenthal. She succeeds Florian Dieckmann, who has played a key role in evolving the company’s Communications department...

20.05.2025, 10:36:02
/
OTE0001

Grünenthal Group

Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal

Aachen, Germany & Toronto, Canada, (OTE) - Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that...

24.02.2025, 15:44:17
/
OTE0001

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

Aachen, Germany (OTE) - Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025.

09.01.2025, 10:27:48
/
OTE0001

Grünenthal Group

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neur

Aachen, Germany/Morristown, N.J. (OTE) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10...